Emcure Pharmaceuticals Limited has announced the closure of its trading window for designated persons and their relatives. This closure is in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. The trading window will be closed effective from Thursday, January 01, 2026. It will remain shut until 48 hours after the declaration of the company's unaudited financial results for the quarter ending December 31, 2025. The date of the Board Meeting to consider and approve these financial results will be communicated in due course. The company has also uploaded this intimation on its official website, www.emcure.com.